Search Results 761-770 of 17089 for saffron dosage

  1. A Study to Evaluate the Effects of N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease) - Mayo Clinic

    If male, the patient agrees not to donate sperm from the first dose until 90 days after dosing. Patients must fall within: A SARA score of 5 ≤ X ≤ 33 ...

  2. Clinical trials - Oncology (Medical)

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  3. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the safety [including dose-limiting toxicities (DLTs)] of the combination therapy of TILT-123 and pembrolizumab in ...

  4. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... dose-limiting toxicities (DLT), maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) when administered as monotherapy, and in combination with ...

  5. Mayo Clinic Minute: How to tell if your child has a fever Video Audio Feeling feverish? The uncomfortable condition signals

    Feel free to call your pediatrician or family doctor to make sure they can give you the right dosing instructions if you have any questions." For the Mayo ...

  6. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

    About this study. The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with ...

  7. Neurology - Clinical trials

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  8. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    ... dosages and risks/benefits. In the later phase (phase 3), researchers study ... dose of other steroid) used for treatment of non-hematologic medical ...

  9. General Internal Medicine - Clinical trials

    ... dose selection and basket design with exploratory single-arm cohorts for various subpopulations of participants. Alleviation By Fisetin Of Frailty ...

  10. Clinical trials - Oncology (Medical)

    The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...